Cipla gains 1% after launching anti-malaria drug for young children News News / News 7 years ago 492 Views comments The company has launched 100 mg Artesunate Rectocaps/Rectal Artesunate Suppositories (RAS), a life-saving, pre-referral intervention for the managemen... Read more
News Six tech-savvy public transport modes could soon be a reality in India News / News - 7 years ago
News Jubilant Foodworks gains over 4% on strong Q1, bullish brokeragesâ stance News / News - 7 years ago
Comments